Bio tech company updates — 8/19/2026
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Lotte Biologics has completed its move to the Songdo bio campus, positioning the company for commercial production targeted for 2027. Separately, Fierce Biotech’s latest workforce tracker reports that Kolon cut staff following a Phase 3 failure.
Key Findings
-
Lotte Biologics completes Songdo relocation: The company has moved all employees to its Songdo bio campus and is accelerating preparations for commercial production targeted for 2027.
Lotte Biologics Songdo campus relocation report -
Kolon workforce reduction reported: Fierce Biotech’s August 2026 layoff tracker lists Kolon among companies that cut workforce after a Phase 3 failure.
Biotechnology workforce reduction tracker illustration
Details
Lotte advances toward commercial production
Lotte Biologics has completed the transfer of its employees to its Songdo bio campus, according to a report published on August 18. The move is described as part of preparations for commercial production scheduled for 2027.
Kolon appears in global workforce tracker
Fierce Biotech’s latest tracker, listed as published 14 hours before the research capture, identifies Kolon in connection with workforce cuts following a Phase 3 failure. The available research result does not provide further details on the affected program, the number of employees, or the timing of the reduction.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
